Last reviewed · How we verify

NCT06673407: OASIS

Group Exposure Workshops for Socially Anxious Undergraduates

Recruiting now NA Last updated 20 May 2025
What this trial tests

NA trial testing Group Exposure for Social Anxiety in Social Anxiety Disorder in 200 participants. Currently enrolling.

Timeline
12 June 2024
Primary endpoint
1 October 2025
1 October 2025

Quick facts

Lead sponsorUniversity of Colorado, Boulder
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingsingle
Primary purposetreatment
Enrollment200
Start date12 June 2024
Primary completion1 October 2025
Estimated completion1 October 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Boulder

Who can join

Adults 18 to 30, any sex, with Social Anxiety Disorder or Public Speaking Fear. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to investigate the effects of four versions of a workshop for social anxiety and public speaking stress. All participants are current University of Colorado Boulder undergraduate students. Participation in this research study lasts for approximately 8 weeks, and includes a pre-workshop questionnaire, 3 weekly workshop sessions (ranging from 2 to 3 hours each, including a 5-minute post-session questionnaire), a post-workshop questionnaire, and a 1-month follow-up questionnaire.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Social Anxiety Disorder

Currently open trials in the same condition.

Other University of Colorado, Boulder trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06673407.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing